Patent · US Active

Protease inhibitors

US10723709B2 · kind B2 · utility

1Cited by

7References

18Claims

0Family size

Assignee

MEDIVIR AB · SE

Inventors

Lourdes Salvador ODEN · Huddinge, SE
Magnus Nilsson · Mölndal, SE
Pia Kahnberg · Huddinge, SE
Bertil Samuelsson · Huddinge, SE
Urszula Grabowska · Huddinge, SE

Key dates

Filing date	Jun 24, 2019
Grant date	Jul 28, 2020
Priority date	—
Expiry date	Jun 24, 2039

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of the formula II: wherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.